Review Articles Concerning Pulmonary Vascular Disease Archives - Page 8 of 21

Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia

Nidhy P. Varghese, Gabriel Altit, Megan M. Gubichuk, Roopa SiddaiahBaylor College of Medicine and Texas Children’s Hospital. Montreal Children’s Hospital and McGill University. Children’s Mercy Hospital. Penn State Health Children’s Hospital.United States and Canada Journal of Clinical MedicineJ Clin Med 2024; 13: DOI: 10.3390/jcm13123417 AbstractAdvances in perinatal intensive care have significantly enhanced the survival rates of […]

Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia Read More »

Meconium Aspiration Syndrome, Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia-A Recipe for Severe Pulmonary Hypertension?

Deepika Sankaran, Jessa Rose A. Li, Satyan LakshminrusimhaUniversity of California, Davis.United States ChildrenChildren 2024; DOI: 10.3390/children11060673 AbstractHypoxic-ischemic encephalopathy (HIE) is the leading cause of mortality among term newborns globally. Infants born through meconium-stained amniotic fluid are at risk of developing meconium aspiration syndrome (MAS) and HIE. Simultaneous occurrence of MAS and HIE is a perilous combination

Meconium Aspiration Syndrome, Hypoxic-Ischemic Encephalopathy and Therapeutic Hypothermia-A Recipe for Severe Pulmonary Hypertension? Read More »

Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review

Chantal Lokhorst, Sjoukje van der Werf, Rolf M. F. Berger, Johannes M. DouwesBeatrix Children’s Hospital, University Medical Center Groningen and University of GroningenNetherlands Journal of the American Heart AssociationJ Am Heart Assoc 2024; DOI: 10.1161/JAHA.123.034151 AbstractBackground: In pulmonary arterial hypertension, it is recommended to base therapeutic decisions on risk stratification. This systematic review aims to report the prognostic value of serial risk

Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review Read More »

Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function

Kenzo Ichimura, Adam Gross, Roy O. Mathew, Loay Salman, Sushma Reddy, Edda Spiekerkoetter, Mandeep S. SidhuStanford University. Albany Medical College. Loma Linda VA Health Care System. United States Cardiovascular Drugs and TherapyCardiovasc Drups Ther 2024; DOI: 10.1007/s10557-024-07588-8 AbstractCardiorenal syndrome (CRS) due to right ventricular (RV) failure is a disease entity emerging as a key indicator of

Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function Read More »

Stenting of the Patent Ductus Arteriosus

Katherine Price, Justin R. Ryan, Howaida El-SaidCincinnati Children’s Hospital Medical Center. Rady Children’s Hospital.United States Interventional Cardiology ClinicsInterv Cardiol Clin 2024; 13: 421-430DOI: 10.1016/j.iccl.2024.02.002 AbstractSince PDA stenting was first attempted in the early 1990s, significant technical advancements have improved outcomes and some centers have even transitioned to exclusive PDA stenting for all infants with duct-dependent pulmonary

Stenting of the Patent Ductus Arteriosus Read More »

The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives

Yunjia Song, Shuo Cao, Xutao Sun, Guozhen ChenHeilongjiang University of Chinese Medicine. The Affiliated Yantai Yuhuangding Hospital.China Mammalian GenomeMamm Genome 2024; DOI: 10.1007/s00335-024-10043-6 AbstractHydrogen sulfide (H2S) is recognized as the third gasotransmitter, after nitric oxide (NO) and carbon monoxide (CO). It is known for its cardioprotective properties, including the relaxation of blood vessels, promotion of angiogenesis,

The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives Read More »

Neonatal perspective on central lymphatic disorders

Brian M. Dulmovits, Dalal K. TahaChildren’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania.United States Seminars in Pediatric SurgerySemin Pediatr Surg 2024; 33:DOI: 10.1016/j.sempedsurg.2024.151424 AbstractLymphatic disorders presenting in the first year of life are difficult to identify and manage given the broad range of underlying etiologies. Neonatal lymphatic disease arising from

Neonatal perspective on central lymphatic disorders Read More »

Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: Diagnosis and treatment

Maxim Itkin, Aaron Chidekel, Kelly A. Ryan, Deborah RabinowitzPerelman School of Medicine at the University of Pennsylvania. Nemours/duPont Hospital for Children. Sidney Kimmel Medical College at Thomas Jefferson University. United States Paediatric Respiratory ReviewsPaediatr Respir Rev 2020; 36: 15-24 DOI: 10.1016/j.prrv.2020.07.001 AbstractPulmonary lymphatic disorders are characterized by the presence of the abnormal lymphatic tissues in the

Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: Diagnosis and treatment Read More »

NLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea

Xiaoting Yangzhong, Shu Hua, Yiqiong Wen, Xiaoqing Bi, Min Li, Yuanyuan Zheng, Shibo SunFirst Affiliated Hospital, Kunming Medical University.China Current Molecular MedicineCurr Mol Med 2024; DOI: 10.2174/0115665240294605240426123650 AbstractObstructive sleep apnea [OSA] is widespread in the population and affects as many as one billion people worldwide. OSA is associated with dysfunction of the brain system that controls

NLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea Read More »